Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P LARSEN

Showing results (221-230 of 814) with videos related to

Pageof 82
Sort By:
The Journal of Clinical Investigation|March 1, 1974
Sulfhydryl groups of the erythrocyte membrane and their relation to glycolysis and drug-induced hemolytic anemiaA Zipursky, M Stephens, E J Brown, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage techniqueNidia C Messias, Patrick D Walker, Christopher P Larsen
Convulsive Therapy|January 23, 1998
Maintenance electroconvulsive therapy for Parkinson's diseaseD Aarsland, J P Larsen, O Waage, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2022
EXT1 and NCAM1-associated membranous lupus nephritis in a cohort of patients undergoing repeat kidney biopsiesPaul P Miller, Tiffany Caza, Christopher P Larsen, et al.
Archives of Neurology|May 18, 1999
Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based studyD Aarsland, J P Larsen, J L Cummins, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 14, 2000
Health related quality of life in Parkinson's disease: a prospective longitudinal studyK H Karlsen, E Tandberg, D Arsland, et al.
Brain : a Journal of Neurology|December 1, 1994
Effects of cholinergic blockade on language in healthy young women. Implications for the cholinergic hypothesis in dementia of the Alzheimer typeD Aarsland, J P Larsen, I Reinvang, et al.
Acta Neurologica Scandinavica|November 12, 2005
The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's diseaseK Haugarvoll, D Aarsland, T Wentzel-Larsen, et al.
Kidney International Reports|July 26, 2022
COVID-19 Infection Does Not Alter HLA Antibody ReactivityAileen C Johnson, Christian P Larsen, Howard Gebel, et al.
Frontiers in Immunology|September 19, 2022
Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejectionMarcos Iglesias, Daniel C Brennan, Christian P Larsen, et al.
Pageof 82

Showing results (221-230 of 814) with videos related to

Sort By:
Pageof 82
The Journal of Clinical Investigation|March 1, 1974
Sulfhydryl groups of the erythrocyte membrane and their relation to glycolysis and drug-induced hemolytic anemiaA Zipursky, M Stephens, E J Brown, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
Paraffin immunofluorescence in the renal pathology laboratory: more than a salvage techniqueNidia C Messias, Patrick D Walker, Christopher P Larsen
Convulsive Therapy|January 23, 1998
Maintenance electroconvulsive therapy for Parkinson's diseaseD Aarsland, J P Larsen, O Waage, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2022
EXT1 and NCAM1-associated membranous lupus nephritis in a cohort of patients undergoing repeat kidney biopsiesPaul P Miller, Tiffany Caza, Christopher P Larsen, et al.
Archives of Neurology|May 18, 1999
Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based studyD Aarsland, J P Larsen, J L Cummins, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 14, 2000
Health related quality of life in Parkinson's disease: a prospective longitudinal studyK H Karlsen, E Tandberg, D Arsland, et al.
Brain : a Journal of Neurology|December 1, 1994
Effects of cholinergic blockade on language in healthy young women. Implications for the cholinergic hypothesis in dementia of the Alzheimer typeD Aarsland, J P Larsen, I Reinvang, et al.
Acta Neurologica Scandinavica|November 12, 2005
The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's diseaseK Haugarvoll, D Aarsland, T Wentzel-Larsen, et al.
Kidney International Reports|July 26, 2022
COVID-19 Infection Does Not Alter HLA Antibody ReactivityAileen C Johnson, Christian P Larsen, Howard Gebel, et al.
Frontiers in Immunology|September 19, 2022
Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejectionMarcos Iglesias, Daniel C Brennan, Christian P Larsen, et al.
Pageof 82